Adam Drapczuk
Fortune : 61 315 $ au 30/06/2026
Fortune : 61 315 $ au 30/06/2026
Adam E.
Drapczuk worked at West-Ward Pharmaceutical Corp.
from 2001 to 2011, serving as Finance Director from 2008 to 2011.
From 2011 to 2016, worked at Tris Pharma, Inc. as Finance Director & Controller.
In 2016, held the position of Chief Financial Officer & Vice President-Finance at Inpellis, Inc. Also in 2016, worked as Financial Controller at R-Pharm US LLC until 2020.
From 2021 to 2025, served as Chief Financial & Accounting Officer at NexGel, Inc., continuing in that role through 2026.
Education includes undergraduate studies at Susquehanna University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
NEXGEL, INC. 1,33 % | 03/06/2026 | 122 385 ( 1,33 % ) | 61 315 $ | 30/06/2026 |
| Sociétés | Poste | Fin |
|---|---|---|
| NEXGEL, INC. | Comptroller/Controller/Auditor | 27/04/2026 |
| NEXGEL, INC. | Directeur Financier/CFO | 31/12/2025 |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of medicines to treat cancer | Comptroller/Controller/Auditor | 01/04/2020 |
Inpellis, Inc.
Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes transdermal prescription therapeutic products | Directeur Financier/CFO | 01/04/2016 |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Directeur Financier/CFO | 01/02/2016 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Susquehanna University
Susquehanna University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
West-Ward Pharmaceutical Corp.
West-Ward Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology Provides generic prescription medication services | Health Technology |
NexGel, Inc.
NexGel, Inc. Chemicals: SpecialtyProcess Industries Manufactures hydrogel compounds | Process Industries |
Tris Pharma, Inc.
Tris Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers therapeutics for ADHD, pain, addiction & central nervous system disorders | Health Technology |
Inpellis, Inc.
Inpellis, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes transdermal prescription therapeutic products | Health Technology |
R-Pharm US LLC
R-Pharm US LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of medicines to treat cancer | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national